The App, called Mobile MIM, has been available for use in Ireland and the UK by medical professionals since December 11 2010.
With the approval US doctors will be able to assess and make clinical decisions of “computed tomography (CT), magnetic resonance imaging (MRI), and nuclear medicine technology, such as positron emission tomography (PET).”
William Maisel, M.D., M.P.H., chief scientist and deputy director for science in the FDA’s Center for Devices and Radiological Health said, “This important mobile technology provides physicians with the ability to immediately view images and make diagnoses without having to be back at the workstation or wait for film.”
Approval of the App in the States, was delayed while the FDA raised concerns that image resolution, screen glare and contrast issues could interfere with diagnosticians’ ability to properly interpret the images.
The FDA was concerned that the screen brightness and ambient light could mask parts of the image needed for a correct diagnosis. The application was passed thanks to its use of screen brightness controls, significant safety warnings and an on-screen safety guide.
However, the FDA warned that the App is not designed as a replacement of medical workstations but should only be used when access to full medical-viewing equipment is not available.
The ITU digital pandemic scenario is like the sequel to Cyber Polygon -- prepping for…
One Way Ventures has announced the dates and lineup for the second edition of the…
Interest in the apartment industry is reaching fever pitch as author Chris Schembra, mogul Barbara…
Let’s take a closer look at ‘Browsergate’: is LinkedIn really running the biggest corporate espionage…
Valencia’s tech ecosystem is getting a big win this June 12-14 as Techstars Startup Weekend announces…
In the upper floors of corporate America, budgets are larger than ever, board presentations are…
View Comments